Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma

Bone Marrow Transplantation

Volumn 20, Issue 6, 1997, Pages 445-450

  Jagannath, S ^a,e   Vesole, D H ^a   Zhang, M ^b   Desikan, K R ^a   Copeland, N ^a   Jagannath, M ^a   Bracy, D ^a   Jones, R ^c   Crowley, J ^d   Tricot, G ^a   Barlogie, B ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Centers for Mental Hlthcare Res   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

High dose melphalan; Multiple myeloma; Outpatient transplant

Indexed keywords

BETA 2 MICROGLOBULIN; CEFALEXIN; CIPROFLOXACIN; ERYTHROMYCIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MELPHALAN; PENICILLIN V; SERUM ALBUMIN;

ADULT; AGE; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUTOGRAFT; BACTEREMIA; CANCER SURVIVAL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; FEMALE; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUTROPENIA; OUTPATIENT; PNEUMONIA; PRIORITY JOURNAL; REMISSION; STEM CELL; STOMATITIS; TREATMENT OUTCOME;

EID: 0030800689     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700900     Document Type: Article

References (19)

1. Barlogie B, Alexanian R, Dicke KA et al. High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma. Blood 1987; 70: 869-872.
2. Phillip T, Armitage JO, Spitzer G et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate grade or high-grade non-Hodgkin's lymphoma. New Engl J Med 1987; 316: 1493-1498.
3. McElwain TJ, Powles RJ. High-dose intravenous melphalan for plasma-cell leukemia and myeloma. Lancet 1983; 1: 822-824.
4. Barlogie B, Hall R, Zander A et al. High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 1986; 67: 1298-1301.
5. Altai M, Huguet F, Schlaifer D et al. Intensive combined therapy for previously untreated aggressive myeloma. Blood 1992; 79: 1130-1136.
6. Anderson KC, Andersen J. Soiffer R et al. Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma. Blood 1993; 82: 2568-2576.
7. Cunningham D, Paz-Ares L, Milan S et al. High dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol 1994; 12: 759-763.
8. Fermand J, Chevret S, Ravaud P et al High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a Phase II trial involving 63 patients. Blood 1993; 82: 2005-2009.
9. Harousseau J, Milpied N, Laporte J et al. Double-intensive therapy in high-risk multiple myeloma. Blood 1992; 79: 2827-2833.
10. Barlogie B, Jagannath S, Vesole DH, Tricot G. Autologous and allogeneic transplants for multiple myeloma. Semin Hematol 1995; 32: 31-44.
11. Jagannath S, Vesole DH, Glenn L et al. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992; 80: 1666-1672.
12. Tricot G, Jagannath S, Vesole DH et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favor-able variables for rapid engraftment in 225 patients. Blood 1995; 85: 588-596.
13. Barlogie B, Alexanian R, Pershouse M et al. Cytoplasmic immunoglobulin content in multiple myeloma. J Clin Invest 1985; 76: 765-769.
14. US Department of Commerce. Statistical Abstract of the United States 1994, 114th edition.
15. Altai M, Harousseau JL, Stoppa AM et al. High dose therapy in multiple myeloma: a prospective randomized study of the 'Intergroupe Francais du Myelome' (IFM). Blood 1994; 84: 386a.
16. Peters WP, Ross M, Vredenburgh JJ et al. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer. Sem Oncol 1994; 21: 25-31.
17. Meisenberg BR, Miller WE, McMillan R et al. Outpatient high-dose chemotherapy with autologous stem-cell rescue for hematologie and nonhematologic malignancies. J Clin Oncol 1997; 159: 11-17.
18. Bennett CL, Armitage JL, Armitage GO et al. Costs of care and outcomes for high-dose therapy and autologous transplantation for lymphoid malignancies: results from the University of Nebraska 1987 through 1991. J Clin Oncol 1995; 13: 969-973.
19. Duan N. Smearing estimate: a nonparametric retransformation method. JASA 1983; 78: 605-610.